戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ibraries, each from an individual pancreatic islet cell.
2 structs transduced in MIN6 cells and primary islet cells.
3 ing pancreas development as well as in adult islet cells.
4 m stage cells (CXCR4+ cells), and pancreatic islet cells.
5 ents IGF-1-induced survival of primary mouse islet cells.
6 lored whether Hes3 also regulates pancreatic islet cells.
7 distinct spatial-temporal patterns in rodent islet cells.
8 transcription factor in developing and adult islet cells.
9  and human pancreas and sorted primary human islet cells.
10 r without (n = 8) intraabdominally engrafted islet cells.
11 omers in pancreatic rat insulinoma and human islet cells.
12 ility of (18)F-fallypride as a PET agent for islet cells.
13 entiation into exocrine acinar and endocrine islet cells.
14 ntiate them, i.e., switch their lineage into islet cells.
15 spensable for the function of differentiated islet cells.
16 us as a gene delivery vehicle for pancreatic islet cells.
17 ival of the second wave of hormone-producing islet cells.
18 models for the differentiation of pancreatic islet cells.
19  precursors failed to mature into functional islet cells.
20 ine Neurog3 expression in hormone-expressing islet cells.
21  exit the cell cycle, and differentiate into islet cells.
22 or RNA sequencing of single mouse pancreatic islet cells.
23  without various indirect effects from other islet cells.
24 demonstrate an acinar cell defect but normal islet cells.
25 ted insulin secretion (GSIS) and survival of islet cells.
26 of live-cell phenotypes in single developing islet cells.
27 , cardiomyocytes, and insulin-producing beta islet cells.
28 aimed to assess these findings in East-Asian islet-cells.
29  secretion by increasing oxidative stress in islets cells.
30 tein-coupled receptors that are expressed by islets cells.
31 ferentiated hESCs as compared with CXCR4+ or islets cells.
32 ifferentiation from acinar, centroacinar and islet cells, accompanied by activation of Notch1 signali
33     Experiments were carried out with single islet cells adherent to chimeric proteins made of functi
34 on of menin in pretumor beta-cells increases islet cell adhesion and reduces cell migration.
35 n beta-cell reconstitution from heterologous islet cells after near-total beta-cell loss in mice.
36 T cells secreting IL-4 or IL-10 specific for islet cell Ag, and causes peripheral deletion of beta-ce
37 vide islet cells with glutamate, (b) protect islet cells against high extracellular glutamate concent
38 n insulin-producing beta-cells in a model of islet cell aggregate formation.
39 roughout the rat genome in normal pancreatic islet cells, allowing us to identify the changes that oc
40 ed in cytokine-treated, HLA class II matched islet cells alone.
41 nhbb or addition of activin B stimulates rat islet cell and beta-cell proliferation, and the activin
42 ates Pdx-1-stimulated proliferation of total islet cells and beta cells.
43 the cell cycle during the differentiation of islet cells and demonstrate that the subsequent down-reg
44 uppressed NF-kappaB activation in both human islet cells and immune cells.
45 SAs bound to allogeneic targets expressed by islet cells and induced their destruction in vitro; howe
46 activation of this pathway is detrimental to islet cells and likely promotes damaging autoimmunity an
47  involved in the terminal differentiation of islet cells and maintenance of islet mass.
48           (18)F-fallypride bound to isolated islet cells and pancreatic sections with an endocrine or
49 and contain time-series expressions in human islet cells and rat INS-1E cells.
50 ODY genes in the development of pancreas and islet cells and to evaluate their significance in regula
51  a reciprocal interaction between pancreatic islet cells and vascular endothelial cells (EC) in which
52 ed with an augmented number of proliferative islet cells and with resistance to streptozotocin-induce
53 eart, lung, liver, pancreas, intestinal, and islet cells), and (c) the application of antibody testin
54 ssion of TRB3 84R in mouse beta cells, human islet cells, and the murine beta cell line MIN6 revealed
55 iabetes-associated autoantibodies, including islet cell antibodies (ICAs), reflect adaptive immunity,
56  were analyzed using radiobinding assays and islet cell antibodies with immunofluorescence during a m
57 atter was defined as repeated positivity for islet-cell antibodies plus for at least 1 of 3 other dia
58                                  Seventy-two islet cell antibody-negative nondiabetic Hispanic women
59              CD8(+) T-cell responses against islet cell antigens, thought to play a central role in d
60 . 9.1%+/-1.1%, P=0.004), and a lower rate of islet cell apoptosis (20.5%+/-2.8% vs. 7.6%+/-2.3%, P=0.
61                           GABA reduced human islet cell apoptosis in culture, such that the yield of
62                          TCDC did not change islet cell apoptosis.
63 he protective mechanism in berberine against islet cell apoptosis.
64 ttachment and growth of primary human or rat islet cells as monolayers on glass surfaces.
65                   Adhesion tests showed that islet cells attached to N-cad/Fc and E-cad/Fc acquired,
66 e 3 years from 22 case children in whom anti-islet cell autoantibodies developed, and 22 matched cont
67 0.5 and 2 years in the children in whom anti-islet cell autoantibodies developed.
68 ssociated antigen-2 antibodies (IA-2As), and islet cell autoantibodies were measured at time of diagn
69  these autoantibodies did not correlate with islet cell autoantibodies.
70 and 22 matched control children who remained islet cell autoantibody-negative in follow-up.
71                  No differences between anti-islet cell autoantibody-positive and -negative children
72                                       ICA69 (islet cell autoantigen 69 kDa) is a protein implicated i
73                             Although several islet cell autoantigens are known, the breadth and spect
74 erogeneity in autoantibody responses against islet cell autoantigens including two polymorphic varian
75 f the microbiome in the pathogenesis of anti-islet cell autoimmunity and type 1 diabetes.
76  the gut microbiome in children in whom anti-islet cell autoimmunity developed.
77                             Evidence of anti-islet cell autoimmunity in type 1 diabetes appears in th
78 e conclude that hypoglycemia in SCHAD-CHI is islet cell-autonomous.
79                     Total pancreatectomy and islet cell autotransplantation (TPIAT) has been increasi
80 y plays a critical role in the regulation of islet cell biology.
81 ival of both MIN6 beta-cells and dissociated islet cells, both at a very low cell-packing density (<
82 anc) mice also had some minor alterations in islet cells, but beta-cell development was not affected.
83 tes (GG) were coencapsulated with pancreatic islet cells by using protamine sulfate as a clinical-gra
84               To investigate whether primary islet cells can produce EXOs, we isolated cells from the
85 , we used the RIP1-Tag2 (RT2) mouse model of islet cell carcinogenesis to identify a genetic locus th
86  differentiation and development, as well as islet cell carcinogenesis.
87 ry neoplasm generated is a highly metastatic islet cell carcinoma of the pancreas.
88 progression, driving the destruction of beta-islet cells, causing hyperglycemia and ultimately death.
89 duced dominant tolerance to porcine neonatal islet cell cluster (NICC) xenografts in mice.
90 perturbed endocrine cell differentiation and islet cell clustering in VEGF-A overexpressing embryos.
91                                     Neonatal islet cell clusters (ICCs) from INSLEA29Y transgenic (LE
92            While alpha and beta cells formed islet cell clusters in control embryos at E16.5, the inc
93 nd (3) diabetic patients receiving fetal pig islet cell clusters xenograft together with a kidney all
94         To test this hypothesis, we examined islet cell composition in a streptozotocin (STZ)-induced
95 e set of islet preparations, we found a mean islet cell composition of 54.5%+/-1.2% insulin-positive,
96 ometry for assessing beta-cell apoptosis and islet cell composition on serial sections of intact isol
97 eration and insulin secretion of dissociated islet cells, contributing to the reduced beta-cell mass
98 n important regulator of gene expression and islet cell coordination.
99  cell type exhibits hallmarks of its primary islet cell counterpart including cell-specific expressio
100  ADK-Is is cell type-selective: treatment of islet cell cultures with ADK-Is increases replication of
101 erleukin-1beta- and interferon-gamma-induced islet cell death in vitro.
102 Diabetes, but the link of hIAPP structure to islet cell death remains elusive.
103                          Flow-sorted ALDH(+) islet cells demonstrate impaired glucose-induced insulin
104  differentiation and islet development while islet cell-derived angiogenic factors promote EC recruit
105 nifested as a pancreatic insulitis with beta-islet cell destruction and systemic glucose intolerance.
106                                  Nrp2 mutant islet cells developed in proper numbers, but had defects
107 r signals identified factors that stimulated islet cell development.
108                                              Islet cells differentiate properly in Galphao(-/-) mutan
109 lls (EC) in which EC-derived signals promote islet cell differentiation and islet development while i
110 in-1 (Ang1), or angiopoietin-2 (Ang2) during islet cell differentiation and islet development.
111 w that the transcription factor Rfx6 directs islet cell differentiation downstream of Neurog3.
112 ndodermal progenitor cells towards endocrine islet cell differentiation during embryogenesis.
113 necessary and sufficient to induce endocrine islet cell differentiation from embryonic pancreatic pro
114 transcription factors that are essential for islet cell differentiation have been well characterized;
115 scription factor neurogenin3 (Ngn3) triggers islet cell differentiation in the developing pancreas.
116        Galphao is not required for endocrine islet cell differentiation, but it regulates the number
117  Neurog3 target genes that are essential for islet cell differentiation, maturation, and function.
118 o parse out the spatiotemporal regulation of islet cell differentiation, we used a Neurog3-Cre allele
119                   Thus, mammalian pancreatic islet cells display cell-type-specific epigenomic plasti
120                Diannexin was administered to islet cell donors shortly before pancreas harvest, added
121 ofound dose-dependent deleterious effects on islet cell engraftment.
122 ion in sites that might be more favorable to islet cell engraftment.
123                                We found that islet cells expressed the genes encoding all of the prod
124                            Here we show that islet cells expressing insulin, glucagon, or somatostati
125 stinct from others in regard to temporal and islet cell expression pattern, with beta-cells affected
126  of pancreatic progenitor cells to adopt the islet cell fate.
127 tory program to correctly specify pancreatic islet cell fates.
128 ucose-regulated hormone secretion, and human islet cells follow a similar pattern.
129 promote growth, function, and engraftment of islet cells following transplantation.
130 eptozotocin (STZ)-treated primary pancreatic islet cells from ICR mice to unravel the protective mech
131 psulation system to protect the transplanted islet cells from immune system attack while allowing the
132 cretion resulting from changes in pancreatic islet cell function and/or mass.
133 study indicated that, from the standpoint of islet cell function, linagliptin would be more effective
134 ors associated with pancreas development and islet cell function, we analyzed how an endogenous delet
135 s toxicity on both renal and pancreatic beta-islet cell function.
136 omoters and enhancers to repress alternative islet cell genes including ghrelin, glucagon, and somato
137 nd in silico replications of mouse and human islet cell genes were performed.
138 type 1 diabetic recipients of an intraportal islet-cell graft under maintenance immunosuppression (IS
139 ressants in 35 type 1 diabetic recipients of islet cell grafts prepared from a median of 6 donors (ra
140          Allosensitization to cultured human islet cell grafts was low when assessed by CDC assay but
141 2 diabetes and contributes to the failure of islet cell grafts.
142  The formation of hIAPP amyloid plaques near islet cells has been linked to the death of insulin-secr
143 sis and proliferation, but during adulthood, islet cells have a very slow turnover.
144            We found a decrease in pancreatic islet cell hyperplasia, fat accumulation in the liver, a
145 as and four additional positive lesions (two islet-cell hyperplasia and two uncharacterised lesions)
146                           One true negative (islet-cell hyperplasia) and one false negative (malignan
147 omotes glucose-stimulated insulin secretion, islet cell hypertrophy, and islet cell proliferation, th
148 he genetic and molecular factors controlling islet cell identity and function.
149 oliferating betaTC-6 cells, but not in human islet cells; (ii) down-regulation of ZBED6 in betaTC-6 c
150 ls at embryonic stages or in Pdx1-expressing islet cells in adults impairs endocrine function, a phen
151 id bilayers, but appear to have no effect on islet cells in culture.
152 ptide-lipid interactions with its effects on islet cells in culture.
153 s) ILT3 induce allogeneic tolerance to human islet cells in humanized NOD/SCID mice.
154 B-dependent fashion) and translated by human islet cells in response to in vitro inflammatory stimuli
155 ed destruction of the insulin-producing beta-islet cells in the pancreas.
156 IL15/IL-15Ralpha expression was increased in islet cells in the prediabetic stage, and inhibition of
157 eptor (D(2)/D(3)R)-based PET method to study islet cells in the rat pancreas and in islet cell transp
158  direct role in the death of pancreatic beta-islet cells in type II diabetes.
159 s surrogate beta-cells and human HLA-A*24(+) islet cells in vitro.
160 e long-term insulin secretion by xenografted islet cells in vivo, and represent a novel contrast agen
161 t on the NOD background despite an increased islet cell infiltrate with markedly increased numbers of
162              A landscape with multiple intra-islet cell interconversion events is emerging, offering
163 rable leakage of the contrast agent into the islet cell interstitium.
164 et amyloid polypeptide (hIAPP) in pancreatic islet cells is implicated in the pathogenesis of type II
165 et, that insulin secretion, intrinsic to the islet cells, is a key mechanism underlying the associati
166 g pancreas and is later restricted to mature islet cells, is involved in the terminal differentiation
167 ssion of miR-29a/b/c in MIN6 and dissociated islet cells led to impairment in glucose-induced insulin
168                  Snord116 may play a role in islet cell lineage specification.
169       The genetic determinants of acinar and islet cell lineages are somewhat well defined; however,
170 TC1 (alphaTC1) and Beta-TC-6 (betaTC6) mouse islet cell lines are cellular models of islet (dys)funct
171 E-seq data from islets to that from five non-islet cell lines revealed approximately 3,300 physically
172 ucose and lipid impair beta cell function in islet cell lines, cultured rodent and human islets, and
173           A noninvasive method that measures islet cell loss and also tracks the fate of transplanted
174 entify how acinar cell proteases cause human islet cell loss before and after transplantation of impu
175                                              Islet cell loss in the pancreas results in diabetes.
176 ent with DXM improved islet insulin content, islet cell mass and blood glucose control.
177  of A1AT to impure islet cultures maintained islet cell mass, restored insulin levels, and preserved
178 m a more rigid structure, often encasing the islet cell mass.
179 cell differentiation, but also for promoting islet cell maturation and maintaining islet function.
180 ted the hypothesis that enriching pancreatic islet cell membranes with EPA, thereby reducing arachido
181 d that a multiparametric approach focused on islet cell metabolic state, mitochondrial integrity, and
182 roach using objective assessments focused on islet cell mitochondrial integrity and in vitro function
183                     When mimicked in newborn islet cells, modifications in the level of specific micr
184                                          The islet cell monolayer cultures on glass stably maintain d
185 initial bursting discharge, Ih currents, and islet cell morphology.
186 tion of glucagon secretion where neighboring islet cells negatively regulate glucagon secretion throu
187 ssion of miR-26a in mice increases postnatal islet cell number in vivo and endocrine/acinar colonies
188 tes to the alteration of beta-cell identity, islet cell numbers and morphology, and gene expression b
189  this pathogenic process was active in human islet cells obtained from donors with type 2 diabetes; t
190 ) is a highly amyloidogenic protein found in islet cells of patients with type II diabetes.
191 ly transcript 1epsilon (RAE1epsilon) in beta-islet cells of the pancreas, we found that RAE1 expressi
192 nolayers of adherent and well-spread primary islet cells on glass coverslips is required for detailed
193       Expression of hIAPP in purified monkey islet cells or a murine beta cell line resulted in pro-h
194 ely 40-microm) pseudoislets using all of the islet cells or only some of the cell types, which allowe
195 e treated with alloxan to destroy pancreatic islet cells, or mock-treated with vehicle, and maintaine
196                                We found that islet cell organization, beta-cell mass, and beta-cell f
197    They suggested a secretin-like hormone of islet cell origin explains WDS and achlorhydria.
198 ), 67 SNPs for type 2 diabetes in pancreatic islet cells (P = 0.003) and the liver (P = 0.003), and 1
199 direct effects of autonomic nervous input on islet cell physiology cannot be studied in the pancreas.
200 down-regulation of Neurog3 allows the mature islet cell population to expand.
201 d expression of HLA class II on transplanted islet cells potentially causing antidonor sensitization
202 ted the hypothesis that HLA-A24 molecules on islet cells present preproinsulin (PPI) peptide epitopes
203                                        Human islet cells process and present PPI(3-11), rendering the
204 ells expressed Sema3a, while central nascent islet cells produced the semaphorin receptor neuropilin
205                  Organ growth and pancreatic islet cell proliferation and mass were examined in sheep
206 slets, Inhbb overexpression stimulates total islet cell proliferation and potentiates Pdx-1-stimulate
207           Accordingly, a higher frequency of islet cell proliferation was detected in Ad5-infected is
208 eported that Pdx-1 overexpression stimulates islet cell proliferation, but the mechanism remains uncl
209 sulin secretion, islet cell hypertrophy, and islet cell proliferation, the latter exclusively through
210 s sufficient to stimulate both rat and human islet cell proliferation.
211                                   Pancreatic islet cells provide the major source of counteractive en
212                   Assays for assessing human islet cell quality, which provide results before transpl
213 ve broader implications on the regulation of islet cell ratios and their ability to effectively respo
214                        When cultured, murine islet cells reassociate to form pseudoislets, which reco
215 enes, including those involved in regulating islet cell recovery and proliferation, and identify addi
216 th coincident enhancement of nuclear Nrf2 in islet cells, reduced beta-cell oxidative stress, and pre
217 ian model can be used to define pathways for islet-cell regeneration in humans.
218                                              Islet cell replacement can effectively treat diabetes bu
219 f disease would require strategies combining islet cell replacement with immunotherapy that are curre
220 ent strategy to examine age-associated human islet cell replication competence and reveal mechanisms
221    Furthermore, a GABAA-R PAM promoted human islet cell replication in vitro.
222  of the embryonic endocrine pancreas and the islet cell replication that occurs in an adult animal.
223 ls of exogenous GABA further increased human islet cell replication.
224                                 The national Islet Cell Resource Center Consortium provides human pan
225 arkably, miR-375 normalization in LP-derived islet cells restores beta-cell proliferation and insulin
226                                    Dispersed islet cells secrete aberrant levels of glucagon and insu
227                                        Acute islet cell secretory responses were determined under fas
228 origins in different germ layers, pancreatic islet cells share many common developmental features wit
229      Guided by an observation that dispersed islet cells spread and adhere well on glass surfaces in
230 ing' genes tested were expressed in purified islet-cell subpopulations with a notable variability, de
231      Applying the method to mouse pancreatic islet-cell subsets, we detected both expected and unknow
232 human gene expression and epigenomic data in islet cell subtypes constitutes a truly valuable resourc
233 ld pancreas preservation and their impact on islet cell survival and function.
234                          GABA improved human islet cell survival and had suppressive effects on human
235 elin promotes pancreatic beta-cell and human islet cell survival and prevents diabetes in streptozoto
236  fluorescence-enhanced (NIR-FE) detection of islet cell-targeting autoantibodies.
237 tecture between alphaTC1/betaTC6 and primary islet cells that can be leveraged in functional (epi)gen
238 lity to sophisticated analyses of pancreatic islet cells that reveal new biological insights, as demo
239 by the disruption of cellular homeostasis in islet cells through the formation of membrane-active oli
240 ial signaling axis that instructs developing islet cells to disperse throughout the pancreas.
241  islets, mouse islets, and dissociated mouse islet cells to restore euglycemia, 3) the generation of
242 ed pseudoislets reconstituted from dispersed islet cells to study alpha-cells with and without variou
243 resentation of insulin epitopes by dispersed islet cells to T cells was impaired, and (iii) the devel
244 h repeated positivity for antibodies against islet cells) together with positivity for at least one o
245 tment option for type 1 diabetes, pancreatic islet cell transformation has been hindered by immune sy
246 ification could potentially lead to improved islet cell transplant outcomes.
247                 The use of tacrolimus in our islet-cell transplant protocol caused an initial 20% red
248                               The promise of islet cell transplantation cannot be fully realized in t
249                                              Islet cell transplantation has limited effectiveness bec
250  analysis plans for future pivotal trials of islet cell transplantation in type 1 diabetes.
251 nts with type 1 diabetes of longer duration, islet cell transplantation may be more effective than me
252  vs placebo (RR 0.60; 95% CI 0.41-0.86), and islet cell transplantation vs medical therapy (RR 0.25;
253 ed inflammatory loss of graft function after islet cell transplantation.
254 red a risk factor for liver, intestinal, and islet cell transplantation.
255 e loss of functional islets after allogeneic islet cell transplantation.
256 ed its efficacy in a rhesus macaque model of islet cell transplantation.
257 study islet cells in the rat pancreas and in islet cell transplantation.
258 ing of allograft injury in humans undergoing islet cell transplantation.
259  CXCR4-CXL12 axis, to promote engraftment of islet cell transplantation.
260 -2 diabetes, and also reduces the success of islet cell transplantation.
261 oon retrograde transvenous obliteration, and islet cell transplantation.
262 so show that for encapsulated rat pancreatic islet cells transplanted into streptozotocin-treated dia
263 2 diabetes and contributes to the failure of islet cell transplants, however the mechanisms of IAPP-i
264  amyloid formation in type 2 diabetes and in islet cell transplants.
265 ng somatic gene transfer in a mouse model of islet cell tumorigenesis, we demonstrate that RHAMM isof
266  neuroendocrine tumors (pNET), also known as islet cell tumors, exhibit a wide range of biologic beha
267 I on blood vessels of spontaneous pancreatic islet-cell tumors in RIP-Tag2 transgenic mice.
268  is essential for pancreatic development and islet cell type differentiation.
269 othesis is based on the assumption that each islet cell type has a specific pattern of miRNA expressi
270 n transcription factor that is essential for islet cell type specification and mature beta cell funct
271 standing of the molecular components of each islet cell type that govern islet (dys)function, particu
272                                      A fifth islet cell type, the ghrelin-producing epsilon cells, is
273 on factor Neurogenin3 (Ngn3) is required for islet-cell type specification.
274 ng Rfx6 failed to generate any of the normal islet cell types except for pancreatic-polypeptide-produ
275  differentiation of the beta-cells and other islet cell types from pancreatic endoderm, but the genet
276 e intra-islet interactions between different islet cell types functions not only to reduce the superf
277 of this homologue reduced the numbers of all islet cell types including the insulin-producing beta-ce
278 icantly affecting the proportions of various islet cell types that do form.
279 c basis for the observed plastic identity of islet cell types, and have implications for beta-cell re
280 ene in mice leads to loss of most pancreatic islet cell types, the functional consequences of Pax6 lo
281 n were detected in macrophages but not other islet cell types.
282 ical to ensure there is a correct balance of islet cell types.
283 ights into genes and pathways characterizing islet cell types.
284 odeficiency mice received transplanted human islet cells under the kidney capsule and adoptively tran
285                   Diminishment of functional islet cells' VTCN1 is caused by the active proteolysis b
286  whether cadherin-mediated adhesion of human islet cells was affected by insulin secretagogues and ex
287           Expression of GABA(A)R subunits in islet cells was confirmed by immunohistochemistry.
288                   Expression of GABA(A)Rs in islet cells was investigated by quantitative PCR, immuno
289      We observed that cadherin expression in islet cells was not affected by insulin secretagogues.
290 human leukocyte antigen (HLA) class I on the islet cells, we examined its expression in subjects with
291 as initiates their differentiation to mature islet cells, we examined the role of Neurog3 in cell cyc
292  The viability and glucose responsiveness of islet cells were assessed in vitro, and in vivo insulin
293                              Cadaveric human islet cells were encapsulated with alginate, poly-l-lysi
294 validate the approach, single rat pancreatic islet cells were rapidly analyzed with optically guided
295                                          Rat islet cells were transplanted into the spleen and visual
296                                          448 islet-cells were captured from three East-Asian non-diab
297 Slc1a2) has been hypothesized to (a) provide islet cells with glutamate, (b) protect islet cells agai
298 ed 622 cells, allowing identification of 341 islet cells with high-quality gene expression profiles.
299 in cytokine-treated and virus-infected human islet cells, with up-regulation of gene networks involve
300  reduces the overall production of endocrine islet cells without significantly affecting the proporti

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top